134 related articles for article (PubMed ID: 11922620)
1. Investigation of antigen delivery route in vivo and imune-boosting effects mediated by pH-sensitive liposomes encapsulated with K(b)-restricted CTL epitope.
Lee KY; Chun E; Seong BL
Biochem Biophys Res Commun; 2002 Apr; 292(3):682-8. PubMed ID: 11922620
[TBL] [Abstract][Full Text] [Related]
2. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
3. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
[TBL] [Abstract][Full Text] [Related]
4. In vivo CTL immunity can be elicited by OVA-linker-beta2m fusion protein.
Qian L; Qian GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):547-52. PubMed ID: 12198554
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
6. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
[TBL] [Abstract][Full Text] [Related]
7. Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide.
Chung SW; Cohen EP; Kim TS
Vaccine; 2004 Jun; 22(20):2547-57. PubMed ID: 15193380
[TBL] [Abstract][Full Text] [Related]
8. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
9. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins.
Wang M; Bai F; Pries M; Buus S; Prause JU; Nissen MH
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3939-45. PubMed ID: 16936108
[TBL] [Abstract][Full Text] [Related]
10. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
11. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses.
Collins DS; Findlay K; Harding CV
J Immunol; 1992 Jun; 148(11):3336-41. PubMed ID: 1588035
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
Jérôme V; Graser A; Müller R; Kontermann RE; Konur A
J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372
[TBL] [Abstract][Full Text] [Related]
14. A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity.
Hayashi A; Wakita H; Yoshikawa T; Nakanishi T; Tsutsumi Y; Mayumi T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
J Control Release; 2007 Jan; 117(1):11-9. PubMed ID: 17126444
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses.
Vogel K; Kantor J; Wood L; Rivera R; Schlom J
Cell Immunol; 1998 Nov; 190(1):61-7. PubMed ID: 9826447
[TBL] [Abstract][Full Text] [Related]
16. H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo.
Tang XD; Wan Y; Chen L; Chen T; Yu ST; Xiong Z; Fang DC; Liang GP; Yang SM
Cancer Res; 2008 Mar; 68(5):1529-37. PubMed ID: 18316618
[TBL] [Abstract][Full Text] [Related]
17. Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery.
Yamasaki Y; Ikenaga T; Otsuki T; Nishikawa M; Takakura Y
Vaccine; 2007 Jan; 25(1):85-91. PubMed ID: 16956699
[TBL] [Abstract][Full Text] [Related]
18. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
19. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
Sheikh NA; Rajananthanan P; Attard GS; Morrow WJ
Vaccine; 1999 Aug; 17(23-24):2974-82. PubMed ID: 10462232
[TBL] [Abstract][Full Text] [Related]
20. The role of T cell antagonism and original antigenic sin in genetic immunization.
Singh RA; Rodgers JR; Barry MA
J Immunol; 2002 Dec; 169(12):6779-86. PubMed ID: 12471109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]